Search - tctmd.com

Displaying 741 - 760 of 1006

Sort: Relevancy | Date

Presentation TCT 2014

Thoughtful Insights

Presenter: Michael J. Mack

September 17, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

The ROX Coupler: Adding Compliance and Reducing Resistance to the Arterial Tree: A Mechanical Treatment for Arterial Hypertension. Results of a Prospective, Randomized, Controlled, Blinded-Endpoint, Multicenter European Trial on Resistant Hypertension

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, Melvin D. Lobo

September 16, 2014

Presentation TCT 2014

First-in-Human Results of an Endovascular Self-Expanding Prosthesis for Carotid Baroreceptor Amplification in Patients with Resistant Hypertension

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, Chandan Devireddy

September 16, 2014

Presentation TCT 2014

Bendavia to Prevent Mitochondrial Transition Pore Opening

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Amir Lerman, C. Michael Gibson

September 16, 2014

Presentation TCT 2014

Mitral Valve Repair vs Replacement: Complementary or Competitive?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Francesco Maisano

September 16, 2014

Presentation TCT 2014

Cyclosporine and the CIRCUS Trial

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Amir Lerman, Michel Ovize

September 16, 2014

Presentation TCT 2014

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia

September 16, 2014

Presentation TCT 2014

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim

September 16, 2014

Presentation TCT 2014

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon

September 16, 2014

Presentation TCT 2014

Clinical Indications for TAVR: Where are We and Where are We Going?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein

September 16, 2014

Presentation TCT 2014

Cases #2 and #3: Essentials of One-Stent and Two-Stent Technique Optimization

Presenter: Shao Liang Chen, Issam D. Moussa, Leif Thuesen, Michael Maeng

September 16, 2014

Presentation TCT 2014

Cases #1 and #2: Overcoming Difficult Radial Access

Presenter: Mauricio G. Cohen, Samir B. Pancholy, Tejas Patel, Michael A. Kutcher

September 16, 2014

Presentation TCT 2014

TCT 475: Triple Antithrombotic Therapy Versus Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Dong Oh Kang

September 15, 2014

Presentation TCT 2014

TCT 474: Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes: The AVIATOR Registry

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Georgios Christodoulidis

September 15, 2014

Presentation TCT 2014

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Harvey D. White

September 15, 2014

Presentation TCT 2014

Reversal of Factor Xa Inhibition

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Lisa K. Jennings

September 15, 2014

Presentation TCT 2014

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Schulte Karl-Ludwig, MD

September 15, 2014

Presentation TCT 2014

Edoxaban in ACS and Atrial Fibrillation: Risk/Benefit Analysis and Future Directions

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Michael D. Ezekowitz

September 15, 2014

Advertisement

Thoughtful Insights

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

The ROX Coupler: Adding Compliance and Reducing Resistance to the Arterial Tree: A Mechanical Treatment for Arterial Hypertension. Results of a Prospective, Randomized, Controlled, Blinded-Endpoint, Multicenter European Trial on Resistant Hypertension

First-in-Human Results of an Endovascular Self-Expanding Prosthesis for Carotid Baroreceptor Amplification in Patients with Resistant Hypertension

Bendavia to Prevent Mitochondrial Transition Pore Opening

Mitral Valve Repair vs Replacement: Complementary or Competitive?

Cyclosporine and the CIRCUS Trial

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Clinical Indications for TAVR: Where are We and Where are We Going?

Cases #2 and #3: Essentials of One-Stent and Two-Stent Technique Optimization

Cases #1 and #2: Overcoming Difficult Radial Access

TCT 475: Triple Antithrombotic Therapy Versus Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation

TCT 474: Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes: The AVIATOR Registry

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Reversal of Factor Xa Inhibition

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

Edoxaban in ACS and Atrial Fibrillation: Risk/Benefit Analysis and Future Directions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content